ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.3697
0.04%
Bitcoin
64,210.74
0.33%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ChemoCentryx Inc (CCXI)

  7. ChemoCentryx Inc (CCXI) News

CCXI

ChemoCentryx (CCXI)

ChemoCentryx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CCXI
DateTimeSourceHeadlineSymbolCompany
10/24/20226:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20226:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20226:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20226:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20226:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20226:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20226:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20226:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20225:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20225:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/24/20225:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
10/20/20228:28AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CCXIChemoCentryx Inc
10/20/20228:27AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CCXIChemoCentryx Inc
10/20/20228:27AMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:CCXIChemoCentryx Inc
10/20/20228:20AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CCXIChemoCentryx Inc
10/20/20228:05AMPR Newswire (US)AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYXNASDAQ:CCXIChemoCentryx Inc
10/20/20227:41AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CCXIChemoCentryx Inc
10/18/20223:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CCXIChemoCentryx Inc
10/17/20227:30AMGlobeNewswire Inc.ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual MeetingsNASDAQ:CCXIChemoCentryx Inc
10/07/20223:36PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
10/05/20227:30AMGlobeNewswire Inc.ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:CCXIChemoCentryx Inc
09/20/20225:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CCXIChemoCentryx Inc
09/20/20225:03AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
09/14/20224:32PMEdgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:CCXIChemoCentryx Inc
09/12/202210:14AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CCXIChemoCentryx Inc
08/31/20224:08PMEdgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:CCXIChemoCentryx Inc
08/24/20227:30AMGlobeNewswire Inc.ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical ConferencesNASDAQ:CCXIChemoCentryx Inc
08/23/20225:02AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
08/18/20223:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
08/09/20223:13PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
 Showing the most relevant articles for your search:NASDAQ:CCXI

Your Recent History

USOTC
CYDY
CytoDyn (QB)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
COOP
Mr Cooper
COIN
SHIBUSD
SHIBA INU
USOTC
SPZI
Spooz (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
TGLO
TheGlobe com (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AMRN
Amarin
NASDAQ
LWLG
Lightwave Logic
USOTC
CGAC
Code Green Apparel (PK)
COIN
BTCUSD
Bitcoin
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
DJT
Trump Media and Technology
NASDAQ
AGBA
AGBA
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved